NS: General Flashcards
NSAIDs vary in their selectivitiy for inhibiting different types of cyclo-oxygenase: selective inhibition of what is associated with LESS GI intolerance?
They vary in their selectivity for inhibiting different types of cyclo-oxygenase; selective inhibition of cyclo-oxygenase-2 is associated with less gastro-intestinal intolerance.
What are two selective inhibitors of cyclo-oxygenase-2?
Etoricixib
Celecoxib
COX-2 selective inhibitors, Diclofenac (what dose daily?) and Ibuprofen (what dose daily?) are associated with an increased risk of thombotic events.
Diclofenac: 150mg daily
Ibuprofen 2.4g daily.
Naproxen 1g daily and lower doses of ibuprofen (1.2g daily and less) have not been associated with increased risk of MI.
List the following in terms of decreasing risk of thrombotic events:
Naproxen 1g daily.
Diclofenac 150mg daily.
Ibuprofen 1.2g daily
Ibuprofen 2.4g daily
Highest risk are both ibu 2.4g and diclofenac 150mg daily.
Then Naproxen 1g daily: lower thrombotic risk.
Low doses of ibuprofen 1.2g daily or less have not been associated with an increased risk.
Seperate the following into those with the highest, intermediate and lowest risk of serious upper gastro-intestinal risk:
Naproxen Ibuprofen indometacin Ketoprofen Piroxicam Ketoprofen Diclofenac Ketorolac Etorixicib
Highest risk:
Piroxicam
Ketoprofen
Ketorolac
Intermediate risk: Indometacin Diclofenac Naproxen Ibuprofen (high-dose)
Lowest:
Ibuprofen (low-dose)
The selective inhibitors of COX-2 are associated with a lower risk of serious upper GI effects than non-selective NSAIDs.
Which of the following is associated with the lowest risk of GI effects?
Naproxen
Ketorolac
Piroxicam
Ketoprofen
Highest risk:
Piroxicam
Ketoprofen
Ketorolac
Intermediate risk: Indometacin Diclofenac Naproxen Ibuprofen (high-dose)
Lowest:
Ibuprofen (low-dose)
The selective inhibitors of COX-2 are associated with a lower risk of serious upper GI effects than non-selective NSAIDs.
Which of the following is associated with the highest risk of GI effects?
Ibuprofen - low dose
Ibuprofen - high dose
Etoricoxib
Celecoxib
Highest risk:
Piroxicam
Ketoprofen
Ketorolac
Intermediate risk: Indometacin Diclofenac Naproxen Ibuprofen (high-dose)
Lowest:
Ibuprofen (low-dose)
The selective inhibitors of COX-2 are associated with a lower risk of serious upper GI effects than non-selective NSAIDs.
Which of the following has the highest risk of causing serious GI effects?
Indometacin Piroxicam Diclofenac Naproxen Ibuprofen - low dose
Highest risk:
Piroxicam
Ketoprofen
Ketorolac
Intermediate risk: Indometacin Diclofenac Naproxen Ibuprofen (high-dose)
Lowest:
Ibuprofen (low-dose)
The selective inhibitors of COX-2 are associated with a lower risk of serious upper GI effects than non-selective NSAIDs.
Serious GI risk of indometacin:
Highest risk:
Piroxicam
Ketoprofen
Ketorolac
Intermediate risk: Indometacin Diclofenac Naproxen Ibuprofen (high-dose)
Lowest:
Ibuprofen (low-dose)
The selective inhibitors of COX-2 are associated with a lower risk of serious upper GI effects than non-selective NSAIDs.
Serious GI risk of naproxen:
Highest risk:
Piroxicam
Ketoprofen
Ketorolac
Intermediate risk: Indometacin Diclofenac Naproxen Ibuprofen (high-dose)
Lowest:
Ibuprofen (low-dose)
The selective inhibitors of COX-2 are associated with a lower risk of serious upper GI effects than non-selective NSAIDs.
Serious GI risk of piroxicam
Highest risk:
Piroxicam
Ketoprofen
Ketorolac
Intermediate risk: Indometacin Diclofenac Naproxen Ibuprofen (high-dose)
Lowest:
Ibuprofen (low-dose)
The selective inhibitors of COX-2 are associated with a lower risk of serious upper GI effects than non-selective NSAIDs.
Serious GI risk of ketorolac
Highest risk:
Piroxicam
Ketoprofen
Ketorolac
Intermediate risk: Indometacin Diclofenac Naproxen Ibuprofen (high-dose)
Lowest:
Ibuprofen (low-dose)
The selective inhibitors of COX-2 are associated with a lower risk of serious upper GI effects than non-selective NSAIDs.
The use of which of the following should be avoided in the management of pain in sickle-cell disease because of possible accumulation of a neurotoxic metabolite that can precipitate seizures:
Paracetamol Ibuprofen Codeine Pethidine Morphine Diamorphine
Pethidine hydrochloride should be avoided if possible because accumulation of a neurotoxic metabolite can precipitate seizures; the relatively short half-life of pethidine hydrochloride necessitates frequent injections.
The use of which of the following is particularly associated with hallucinations and thought disturbances:
Oxycodone Morphine Papaveretum Penazocine Pethidine
Pentazocine has both agonist and antagonist properties and precipitates withdrawal symptoms, including pain in patients dependent on other opioids. By injection it is more potent than dihydrocodeine tartrate or codeine phosphate, but hallucinations and thought disturbances may occur. It is not recommended and, in particular, should be avoided after myocardial infarction as it may increase pulmonary and aortic blood pressure as well as cardiac work.
Anticholinesterases are used 1st line in what type of myasthenia gravis?
Anticholinesterases are used as first-line treatment in ocular myasthenia gravis and as an adjunct to immunosuppressant therapy for generalised myasthenia gravis.
Anticholinesterases are used as an adjunct to immunosuppresant therapy in what type of myasthenia gravis?
Anticholinesterases are used as first-line treatment in ocular myasthenia gravis and as an adjunct to immunosuppressant therapy for generalised myasthenia gravis.
Anticholinesterases are used as first-line treatment in ocular myasthenia gravis and as an adjunct to immunosuppressant therapy for generalised myasthenia gravis.
Corticosteroids are used when anticholinesterases do not control symptoms completely.
What is frequently used to reduce the dose of corticosteroid?
Corticosteroids are used when anticholinesterases do not control symptoms completely. A second-line immunosuppressant such as azathioprine is frequently used to reduce the dose of corticosteroid.
Plasmapheresis or infusion of intravenous immunoglobulin [unlicensed indication] may induce temporary remission in severe relapses, particularly where bulbar or respiratory function is compromised or before thymectomy.
Muscarinic side effects of anticholinesterase inhibitors includes what? (6)
What are these effects reversed by?
Muscarinic side-effects of anticholinesterases include increased sweating, increased salivary and gastric secretions, increased gastro-intestinal and uterine motility, and bradycardia.
These parasympathomimetic effects are antagonised by atropine sulfate.
Myasthenia Gravis: Neostigmine produces a therapeutic effect for up to how long?
Neostigmine produces a therapeutic effect for up to 4 hours. Its pronounced muscarinic action is a disadvantage, and simultaneous administration of an antimuscarinic drug such as atropine sulfate or propantheline bromide may be required to prevent colic, excessive salivation, or diarrhoea.
In severe disease neostigmine can be given every 2 hours.
The maximum that most patients can tolerate is 180 mg daily.
Which of the following statements is incorrect?
Neostigmine produces a therapeutic effect for up to 4 hours.
Its pronounced muscarinic action is a disadvantage, and simultaneous administration of an antimuscarinic drug such as atropine sulfate or propantheline bromide may be required to prevent colic, excessive salivation, or diarrhoea.
In severe disease neostigmine can be given every 2 hours.
The maximum that most patients can tolerate is 200 mg daily.
The maximum that most patients can tolerate is 180 mg daily.
How does Pyridostigmine compate to neostigmine?
Pyridostigmine bromide is less powerful and slower in action than neostigmine but it has a longer duration of action. It is preferable to neostigmine because of its smoother action and the need for less frequent dosage. It is particularly preferred in patients whose muscles are weak on waking. It has a comparatively mild gastrointestinal effect but an antimuscarinic drug may still be required.